Refine by MP, party, committee, province, or result type.

Results 1-7 of 7
Sorted by relevance | Sort by date: newest first / oldest first

Health committee  Our examination of shortages—which we had already begun a year ago—revealed that more than 43% of shortages had to do with manufacturing quality, so products that did not meet either Health Canada or FDA standards. So there is a significant responsibility at all levels. The curr

March 29th, 2012Committee meeting

Diane Lamarre

Health committee  I do believe, however, that no country has experienced as widespread of a shortage as what Canada is going through. Right now, injectable drugs are severely affected in Canada. I believe it is incumbent upon us to learn from this specific case. I think it is in our best interests

March 29th, 2012Committee meeting

Diane Lamarre

Health committee  We are convinced that a mandatory system is necessary, because there is the issue of the ability to respond to these shortages as well as the required response time. We are seeing that right now. Findings have been made. At the end of the day, the Sandoz case brings to light all

March 29th, 2012Committee meeting

Diane Lamarre

Health committee  Sandoz already has supply contracts with Canada's three biggest wholesalers. Unfortunately, it's become clear that was not enough to meet the needs. Our three conditions overlap to an extent. For instance, we will certainly want to protect essential painkillers like morphine and

March 29th, 2012Committee meeting

Diane Lamarre

Health committee  Of course, there are measures in place around the world. The current president of the Ordre national des pharmaciens de France, France's national order of pharmacists, is also the president of the European Union group. We can therefore assume that the message approved in France w

March 29th, 2012Committee meeting

Diane Lamarre

Health committee  We are not trying to place the blame here, but rather to find solutions. Across Canada, the responsibility for this complex mechanism is shared by federal and provincial entities. We have a many ties with European countries. As my colleague from the Association des pharmaciens d

March 29th, 2012Committee meeting

Diane Lamarre

Health committee  Madam Chair, members of the committee, we thank you for providing the Ordre des pharmaciens du Québec with the opportunity to discuss disruptions in the drug supply and, especially, potential solutions for preventing those shortages and limiting their impact on the health of Cana

March 29th, 2012Committee meeting

Diane Lamarre